HIV-positive TB patients on ART (antiretroviral therapy) in Eastern Mediterranean (WHO region)
Eastern Mediterranean (WHO region): HIV-positive TB patients on ART (antiretroviral therapy) was 81.0% in 2024. ▲ Rising
HIV-positive TB patients on ART (antiretroviral therapy) in Eastern Mediterranean (WHO region), 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Eastern Mediterranean (WHO region) recorded 81.0% for hiv-positive tb patients on art (antiretroviral therapy) in 2024.
The figure is up 9.5% on the previous year and up 28.6% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Eastern Mediterranean (WHO region) peaked at 85.0% in 2019 and was at its lowest, 13.0%, in 2006.
The long-run direction has been consistently rising across the 22 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Eastern Mediterranean (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 23.0% | — |
| 2004 | 16.0% | -30.4% |
| 2005 | 17.0% | +6.2% |
| 2006 | 13.0% | -23.5% |
| 2007 | 55.0% | +323.1% |
| 2008 | 43.0% | -21.8% |
| 2009 | 41.0% | -4.7% |
| 2010 | 44.0% | +7.3% |
| 2011 | 33.0% | -25.0% |
| 2012 | 60.0% | +81.8% |
| 2013 | 46.0% | -23.3% |
| 2014 | 63.0% | +37.0% |
| 2015 | 72.0% | +14.3% |
| 2016 | 74.0% | +2.8% |
| 2017 | 77.0% | +4.1% |
| 2018 | 78.0% | +1.3% |
| 2019 | 85.0% | +9.0% |
| 2020 | 79.0% | -7.1% |
| 2021 | 72.0% | -8.9% |
| 2022 | 84.0% | +16.7% |
| 2023 | 74.0% | -11.9% |
| 2024 | 81.0% | +9.5% |
Biggest year-on-year movements
Years where HIV-positive TB patients on ART (antiretroviral therapy) in Eastern Mediterranean (WHO region) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2007 | +323.1% | 13.0% | 55.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 29.7% | 13.0% | 55.0% | 7 |
| 2010s | 63.2% | 33.0% | 85.0% | 10 |
| 2020s | 78.0% | 72.0% | 84.0% | 5 |
More health data for Eastern Mediterranean (WHO region)
- Neonatal tetanus - number of reported cases, gaps filled 482 (2025)
- Total tetanus - number of reported cases, gaps filled 524 (2025)
- Diphtheria - number of reported cases, gaps filled 5,830 (2025)
- Pertussis - number of reported cases, gaps filled 14,992 (2025)
- Measles - number of reported cases, gaps filled 83,590 (2025)
- Number of under-five deaths, annual growth rate -2.69 % change on previous year (2024)
- Number of infant deaths, annual growth rate -2.36 % change on previous year (2024)
- Number of neonatal deaths, annual growth rate -2.01 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate 6.13 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate 140.84 % change on previous year (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Eastern Mediterranean (WHO region)?
- Hiv-positive tb patients on art (antiretroviral therapy) in Eastern Mediterranean (WHO region) was 81.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Eastern Mediterranean (WHO region)?
- The highest recorded value was 85.0% in 2019.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Eastern Mediterranean (WHO region)?
- The lowest recorded value was 13.0% in 2006.
- How does Eastern Mediterranean (WHO region) rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Eastern Mediterranean (WHO region) ranks 8th out of 11 groups with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Eastern Mediterranean (WHO region)?
- Over the last ten years it is up 28.6%. The long-run trend across the full record is rising.
- Where does this Eastern Mediterranean (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 22 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).